145 related articles for article (PubMed ID: 31912680)
41. A case of three rare uterine neoplasms in the same surgical specimen.
Giuliani A; Romano L; Romanzi F; Giubbolini G; Coletti G; Di Stefano N; Le'Clerc JN; Schietroma M; Carlei F; Di Stefano L
Ann Ital Chir; 2020 Jan; 9():. PubMed ID: 32129176
[TBL] [Abstract][Full Text] [Related]
42. The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment Outcomes.
Nathenson MJ; Conley AP; Lin H; Fleming N; Lazar A; Wang WL; Ravi V
Int J Gynecol Cancer; 2018 Sep; 28(7):1297-1310. PubMed ID: 30044322
[TBL] [Abstract][Full Text] [Related]
43. Uterine sarcomas 2013.
Sutton G
Gynecol Oncol; 2013 Jul; 130(1):3-5. PubMed ID: 23769183
[No Abstract] [Full Text] [Related]
44. Academic Facility Utilization and Survival Outcomes in Adult Head and Neck Sarcomas: An NCDB Analysis.
Cannon RB; Carpenter PS; Boothe D; Buchmann LO; Hunt JP; Lloyd S; Hitchcock YJ; Houlton JJ; Weis JR; Shepherd HM; Monroe MM
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):473-483. PubMed ID: 29661049
[TBL] [Abstract][Full Text] [Related]
45. A Population-Based Examination of the Surgical Outcomes for Patients with Esophageal Sarcoma.
Wu GX; Ituarte PH; Paz IB; Kim J; Raz DJ; Kim JY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1310-7. PubMed ID: 26310279
[TBL] [Abstract][Full Text] [Related]
46. Significance of Malignant Peritoneal Cytology on Survival of Women with Uterine Sarcoma.
Matsuo K; Matsuzaki S; Nusbaum DJ; Ki S; Chang EJ; Klar M; Roman LD
Ann Surg Oncol; 2021 Mar; 28(3):1740-1748. PubMed ID: 33063261
[TBL] [Abstract][Full Text] [Related]
47. Clinicopathologic features, outcomes, and prognostic factors of testicular sarcoma: a population-based study.
Bhambhvani HP; Greenberg DR; Kasman AM; Eisenberg ML
Int Urol Nephrol; 2021 Feb; 53(2):257-267. PubMed ID: 32895865
[TBL] [Abstract][Full Text] [Related]
48. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
49. Staging of uterine sarcomas.
Tse KY; Crawford R; Ngan HY
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
[TBL] [Abstract][Full Text] [Related]
50. Prognostic factors in uterine sarcoma.
Gadducci A
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):783-95. PubMed ID: 21764643
[TBL] [Abstract][Full Text] [Related]
51. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
52. Natural history and outcome of neuroendocrine carcinoma of the cervix.
Margolis B; Tergas AI; Chen L; Hou JY; Burke WM; Hu JC; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2016 May; 141(2):247-254. PubMed ID: 26873865
[TBL] [Abstract][Full Text] [Related]
53. Significance of lymph node metastasis on survival of women with uterine adenosarcoma.
Machida H; Nathenson MJ; Takiuchi T; Adams CL; Garcia-Sayre J; Matsuo K
Gynecol Oncol; 2017 Mar; 144(3):524-530. PubMed ID: 28109626
[TBL] [Abstract][Full Text] [Related]
54. Uterine Sarcomas: Experience from a Tertiary Cancer Care Center from India.
Nusrath S; Bafna S; Rajagopalan R; Thammineedi SR; Raju KVVN; Patnaik SC; Pawar S; Reddy Y; Chavali RN; Murthy SS
Indian J Surg Oncol; 2019 Jun; 10(2):342-349. PubMed ID: 31168260
[TBL] [Abstract][Full Text] [Related]
55. Müllerian adenosarcoma of the uterine cervix with heterologous elements: a light and electron microscopic study.
Roth LM; Pride GL; Sharma HM
Cancer; 1976 Apr; 37(4):1725-36. PubMed ID: 177174
[TBL] [Abstract][Full Text] [Related]
56. Uterine sarcoma 2008.
Lin JF; Slomovitz BM
Curr Oncol Rep; 2008 Nov; 10(6):512-8. PubMed ID: 18928666
[TBL] [Abstract][Full Text] [Related]
57. Rhabdomyosarcoma of the lower female genital tract: an analysis of 144 cases.
Nasioudis D; Alevizakos M; Chapman-Davis E; Witkin SS; Holcomb K
Arch Gynecol Obstet; 2017 Aug; 296(2):327-334. PubMed ID: 28634755
[TBL] [Abstract][Full Text] [Related]
58. Histologic type predicts survival in patients with retroperitoneal soft tissue sarcoma.
Tseng W; Martinez SR; Tamurian RM; Borys D; Canter RJ
J Surg Res; 2012 Jan; 172(1):123-30. PubMed ID: 20869082
[TBL] [Abstract][Full Text] [Related]
59. Prognostic factors and treatment modalities in uterine sarcoma.
El Husseiny G; Al Bareedy N; Mourad WA; Mohamed G; Shoukri M; Subhi J; Ezzat A
Am J Clin Oncol; 2002 Jun; 25(3):256-60. PubMed ID: 12040283
[TBL] [Abstract][Full Text] [Related]
60. A California Cancer Registry Analysis of Urothelial and Non-urothelial Bladder Cancer Subtypes: Epidemiology, Treatment, and Survival.
Martin JW; Jefferson FA; Huang M; Sung JM; Chang J; Piranviseh K; Ziogas A; Anton-Culver H; Youssef RF
Clin Genitourin Cancer; 2020 Jun; 18(3):e330-e336. PubMed ID: 32144047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
